Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19
The dysfunctional effects of the coronavirus disease 2019 (COVID-19) infection on the nervous system are established. The manifestation of neuropsychiatric symptoms during and after infection is influenced by the neuroinvasive and neurotrophic properties of SARS-CoV-2 as well as strong inflammation...
Main Authors: | Eliza Dąbrowska, Beata Galińska-Skok, Napoleon Waszkiewicz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/10/1056 |
Similar Items
-
The Effect of Antidepressant Treatment on Neurocognitive Functions, Redox and Inflammatory Parameters in the Context of COVID-19
by: Eliza Samaryn, et al.
Published: (2023-11-01) -
Prevalence of neurocognitive disorders and depression in a Brazilian HIV population
by: Flávio Trentin Troncoso, et al.
Published: (2015-08-01) -
A Case Study of Neurocognitive Disorders/Dementia: 2015 Self-Learning Module
by: Martin Klapheke
Published: (2015-09-01) -
Mindfulness Awareness Is Associated With a Lower Risk of Anxiety and Depressive Symptoms in Older Adults With Neurocognitive Disorders
by: Linda Chiu Wa Lam, et al.
Published: (2021-10-01) -
The Role of Microglia in Perioperative Neurocognitive Disorders
by: Wenguo Fan, et al.
Published: (2020-08-01)